Edison / Seattle / Houston / Boston / New York / Philadelphia / Haifa / Danville / Portsmouth / Los Angeles / Cleveland / San Diego / Chicago / /
Company
Fox Chase / Novocure Limited / /
Continent
Europe / /
Country
United States / / /
Facility
Northwestern University / Memorial Hermann Hospital / Memorial Sloan Kettering Cancer Center / Columbia University Medical Center / Mischer Neuroscience Institute / University of Washington / New Jersey Neuroscience Institute / Texas Health Science Center / University of Illinois Hospital / The Ohio State University / The Cleveland Clinic / University of California San Diego Moores Cancer Center / Beth Israel Deaconess Medical Center / Fred Hutchinson Cancer Research Center / Fox Chase Cancer Center / University of California / /
IndustryTerm
non-invasive medical device / platform technology / care for this difficult to treat disease / /
MedicalCondition
Treat Most Common Brain Tumor / histologically-confirmed glioblastoma multiforme / solid tumors / mild-tomoderate rash / primary brain tumor / recurrent glioblastoma multiforme / recurrent glioblastoma brain tumors / slow and reverse tumor / tumor / cancer / disease / prestigious cancer / /
University of Washington / Memorial Hermann Hospital / Arthur G. James Cancer Center / Beth Israel Deaconess Medical Center / The Ohio State University / Columbus / of California San Diego Moores Cancer Center / University of Illinois Hospital / Northwestern University / Chicago / Brain and Spine Tumor Center / Department of Neurosurgery / Columbia University Medical Center / U.S. Food and Drug Administration / Memorial Sloan Kettering Cancer Center / University of California San Diego Moores Cancer Center / University of California / San Francisco / Mischer Neuroscience Institute / New Jersey Neuroscience Institute / Texas Health Science Center / Fred Hutchinson Cancer Research Center / /
Person
Andrew Lassman / Arthur G. James / Jeffrey Raizer / Eric T. Wong / Lisa DeAngelis / Maciej M. Mrugala / Robert Cavaliere / Thomas Chen / Nicholas Butowski / Herbert Engelhard / Gene H. Barnett / Tara Morrison / Joseph Landolfi / Santosh Kesari / Gabe Leung / Peter Melnyk Pmelnyk / Beth Israel / / /
Position
physician / Chairman / /
ProvinceOrState
Texas / New Jersey / Ohio / Illinois / New York / Washington / Pennsylvania / California / Massachusetts / New Hampshire / /
Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified